Artificial intelligence: The real impact for medecine
Animated by Martin Venzal, editot-in-chief of Touleco
1.”AI: possibilities for the healthcare service”
Per Atle Bakkevoll, Senior Advisor at the Norwegian Centre for E-health Research
The Norwegian Centre for E-health Research has made a report on this topic. The aim of the report is to describe and explain the different concepts related to AI. This presentation will present these different concepts and explain the potential of AI for today’s healthcare service.
2. “Big and Small Data for image-based personalised medicine”
Pr. Adrien Depeursinge
Medical images have evolved enormously to become extremely rich and complex sources of scientific data. However, humans are not the best solution when it comes to making a comprehensive and reproducible analysis of this data. Artificial intelligence (AI) is capable of providing a quantitative analysis of the images, revealing correspondences between the pixels and the manifestation of a pathology. The superiority of AI has already been demonstrated in the context of dermopathies, pneumopathies and retinopathies, especially when large volumes of data – known as “big data” – are available. However, alongside the importance of bringing together enormous collections of quality data, “big data” AI models have the disadvantage of being hard to interpret. For this reason, “small data” is also of great interest as it gives back control to healthcare professionals by providing them with an intuition about the information used by the models created and their limitations.
In this talk we will present two “small data” web platforms and explain how they are used for clinical research.
3.”The role of artificial intelligence in therapeutic support”
Rémy Choquet, Director of Innovation and Strategic Foresight at Orange Healthcare
Even though the use of smartphones has today become the norm, the use of new connected objects is becoming more widespread, hospitals are generating ever more data, and new data analysis methods are being developed, we continue to imagine new prevention, diagnosis and follow-up tools that aim to optimise the “patient-healthcare system” relationship. From the detection of inflammation attacks in rheumatoid arthritis thanks to experiments developed with Sanoia in the Rheumatology Department of the AP-HP Paris Public Hospital Group, to therapeutic support for breast cancer thanks to a study conducted at the Centre Léon Bérard and in collaboration with Biomouv. Orange Healthcare is innovating with players from healthcare and research to introduce these new technologies into actual use and is accompanying the organisational mutations of the healthcare system.